NEW YORK (GenomeWeb News) – Fluidigm and Life Technologies' Applied Biosystems business have agreed to end legal actions against each other related to Fluidigm's BioMark System, a Fluidigm spokesperson told GenomeWeb Daily Newstoday.

The firms agreed to dismiss the case, which was filed by Fluidigm against ABI in June 2008, last week, according to court documents. Howard High, the Fluidigm spokesman, told GWDN that the agreement does not include the exchange of any money or any licensing of products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.